Pacira BioSciences CEO Frank D. Lee shares three core tenants to improve biopharmaceutical company leadership, especially companies with products capable of disrupting an established therapeutic area.

Megan Chacon, a principal at Fish & Richardson and a member of the firm’s life sciences industry team, answers questions ...

Imagine a gem hunter facing a vast and uncharted landscape to uncover a single beautiful diamond. It is a bit like drug ...

A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

With just the click of a button on your smartphone, you can order virtually anything and have it on your doorstep in one or ...

It’s not as much of a stretch as you might think. I’ve always loved bikes. In my early 20s, I was a competitive athlete in ...

Approximately one in eight women in the U.S. will be diagnosed with breast cancer during their lifetime. Nearly 30 percent of women who are diagnosed with early-stage breast cancer will eventually ...

In the world of biopharmaceutical innovation, groundbreaking scientific discoveries often do not directly translate into commercial success. Simply developing a promising therapeutic based on great ...

Disagreements about budgets can delay or stall drug development. As the clinical research industry experiences unprecedented rises in costs, having the most current data available when creating and ...

No drug is free from risks, and no two human anatomies are completely identical (meaning different individuals can face different risks), but from a real-world patient perspective — anecdotally — the ...

Then: In 2016, when former Life Science Leader editor Rob Wright wrote about cofounder Peter Hecht and Ironwood Pharmaceuticals, the company was ascending. After its initial launch in 1998, the ...

Globalization presents both opportunities and challenges for the pharmaceutical industry. Companies must navigate diverse regulatory landscapes, ensuring compliance while maintaining product quality.